rs10783218

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000376.3(VDR):​c.146+8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0452 in 1,614,062 control chromosomes in the GnomAD database, including 2,494 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.074 ( 751 hom., cov: 32)
Exomes 𝑓: 0.042 ( 1743 hom. )

Consequence

VDR
NM_000376.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0001908
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.85

Publications

20 publications found
Variant links:
Genes affected
VDR (HGNC:12679): (vitamin D receptor) This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]
VDR Gene-Disease associations (from GenCC):
  • vitamin D-dependent rickets, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • vitamin D-dependent rickets, type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 12-47878960-G-A is Benign according to our data. Variant chr12-47878960-G-A is described in ClinVar as Benign. ClinVar VariationId is 308886.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VDRNM_000376.3 linkc.146+8C>T splice_region_variant, intron_variant Intron 3 of 9 ENST00000549336.6 NP_000367.1 P11473-1F1D8P8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VDRENST00000549336.6 linkc.146+8C>T splice_region_variant, intron_variant Intron 3 of 9 1 NM_000376.3 ENSP00000449573.2 P11473-1

Frequencies

GnomAD3 genomes
AF:
0.0744
AC:
11316
AN:
152090
Hom.:
746
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.178
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0369
Gnomad ASJ
AF:
0.0228
Gnomad EAS
AF:
0.0487
Gnomad SAS
AF:
0.0450
Gnomad FIN
AF:
0.0192
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0359
Gnomad OTH
AF:
0.0703
GnomAD2 exomes
AF:
0.0450
AC:
11311
AN:
251350
AF XY:
0.0431
show subpopulations
Gnomad AFR exome
AF:
0.184
Gnomad AMR exome
AF:
0.0221
Gnomad ASJ exome
AF:
0.0220
Gnomad EAS exome
AF:
0.0486
Gnomad FIN exome
AF:
0.0222
Gnomad NFE exome
AF:
0.0368
Gnomad OTH exome
AF:
0.0381
GnomAD4 exome
AF:
0.0422
AC:
61654
AN:
1461854
Hom.:
1743
Cov.:
30
AF XY:
0.0421
AC XY:
30605
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.193
AC:
6476
AN:
33476
American (AMR)
AF:
0.0235
AC:
1052
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0225
AC:
587
AN:
26136
East Asian (EAS)
AF:
0.0550
AC:
2185
AN:
39698
South Asian (SAS)
AF:
0.0494
AC:
4265
AN:
86254
European-Finnish (FIN)
AF:
0.0236
AC:
1260
AN:
53402
Middle Eastern (MID)
AF:
0.0609
AC:
351
AN:
5768
European-Non Finnish (NFE)
AF:
0.0383
AC:
42587
AN:
1112004
Other (OTH)
AF:
0.0479
AC:
2891
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3692
7384
11077
14769
18461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1748
3496
5244
6992
8740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0745
AC:
11339
AN:
152208
Hom.:
751
Cov.:
32
AF XY:
0.0720
AC XY:
5356
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.178
AC:
7393
AN:
41498
American (AMR)
AF:
0.0367
AC:
562
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0228
AC:
79
AN:
3472
East Asian (EAS)
AF:
0.0486
AC:
252
AN:
5180
South Asian (SAS)
AF:
0.0452
AC:
218
AN:
4822
European-Finnish (FIN)
AF:
0.0192
AC:
204
AN:
10618
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0359
AC:
2443
AN:
67992
Other (OTH)
AF:
0.0691
AC:
146
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
505
1010
1514
2019
2524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0497
Hom.:
759
Bravo
AF:
0.0801
Asia WGS
AF:
0.0590
AC:
204
AN:
3478
EpiCase
AF:
0.0384
EpiControl
AF:
0.0386

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vitamin D-dependent rickets type II with alopecia Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.97
DANN
Benign
0.71
PhyloP100
-1.8
PromoterAI
0.0021
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10783218; hg19: chr12-48272743; API